Sign in
WithdrawnNo phase

Mycobiome Supporting Diet to Reduce GI Toxicity Associated With ASCT

Key facts

Who runs it
Case Comprehensive Cancer Center
Where
Cleveland, United StatesSee the site
Trial code
Status
Withdrawn
Started
1 Apr 2024
Ended
30 Jun 2025
Type of study
Interventional
Treatments tested
  • Mycobiome Supporting Diet
Record updated
26 April 2024
Why it stopped
Administrative decision

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Eligible for first autologous transplant for myeloma
  • Willing to adhere to the allowed and disallowed foods of the diet plan
  • Able to get and prepare their own food items for all meals during the study

Who cannot take part

  • Prior bowel resection
  • Patients who received antifungal therapy in 3 days prior to enrollment
  • Patients who received steroid therapy in 7 days prior to enrollment
  • Active inflammatory bowel disease, celiac disease, other chronic intestinal disorders
  • Inability to tolerate the study diet due to allergies/ intolerance/ preference
  • Any condition that the investigator feels may limit the volunteer's ability to complete the study protocol
  • Patients with absolute neutrophil count (ANC) < 1000 on long term antibacterial prophylaxis ongoing 3 days prior to enrollment
  • Pregnant women, planning to get pregnant or breastfeeding
  • Inability to consent to trial
  • Patients with restrictions in diet including inability to have oral nutrition with regular consistency

Where in United States

  • University Hospitals Cleveland Medical Center, Case Comprehensive Cancer CenterCleveland, United States

About the trial

What the trial wants to find out

The purpose of this study is to determine if this specific Mycobiome Supporting Diet (MSD diet) can help reduce gut inflammation during post-transplant period. The MSD is an special diet which will be explained in detail by a dietician that works by supporting the body's good gut bacteria and fungi.

The group in the trial

  • Mycobiome Supporting DietTreatment being tested

    Participants will be able to abide by the allowed and disallowed foods in MSD diet for at least four consecutive weeks prior to conditioning and up to 10 days after transplant. Participants will maintain a diary of foods they consume and any adverse effects they are experiencing and will self- collect fecal samples 28 days before transplant, 2 days before transplant and 10 days after transplant

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Mycobiome Supporting Diet (MSD) to Reduce Gastrointestinal (GI) Toxicity Associated With Autologous Stem Cell Transplant (ASCT) For Patients With Multiple Myeloma (MM)
Record updated
26 April 2024